Nyxoah SA EPS - Earnings per Share 2021-2025 | NYXH

Nyxoah SA eps - earnings per share from 2021 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Nyxoah SA Annual EPS
2024 $-1.96
2023 $-1.67
2022 $-1.27
2021 $-1.37
2020 $-0.77
Nyxoah SA Quarterly EPS
2025-03-31 $-0.63
2024-12-31 $-0.50
2024-09-30 $-0.55
2024-06-30 $-0.46
2024-03-31 $-0.45
2023-12-31 $-0.40
2023-09-30 $-0.29
2023-06-30 $-0.49
2023-03-31 $-0.49
2022-12-31 $-0.53
2022-09-30 $-0.24
2022-06-30 $-0.21
2022-03-31 $-0.29
2021-12-31 $0.00
2021-06-30 $0.00
2021-03-31 $-0.31
2020-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.280B $0.005B
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.130B 58.69
Doximity (DOCS) United States $11.290B 52.27
Hims & Hers Health (HIMS) United States $11.277B 117.16
Tempus AI (TEM) United States $10.557B 0.00
IRhythm Technologies (IRTC) United States $4.350B 0.00
Inspire Medical Systems (INSP) United States $3.741B 58.45
Hinge Health (HNGE) United States $3.664B 0.00
Privia Health (PRVA) United States $2.391B 163.42
Schrodinger (SDGR) United States $1.574B 0.00
Phreesia (PHR) United States $1.516B 0.00
Enovis (ENOV) United States $1.502B 8.37
Clover Health Investments (CLOV) United States $1.496B 0.00
10x Genomics (TXG) United States $1.496B 0.00
Azenta (AZTA) United States $1.427B 66.30
Omnicell (OMCL) United States $1.259B 22.22
Evolent Health (EVH) United States $1.119B 95.30
Claritev (CTEV) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.541B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Butterfly Network (BFLY) United States $0.462B 0.00
Talkspace (TALK) United States $0.415B 124.00
TruBridge (TBRG) United States $0.336B 746.33
Outset Medical (OM) United States $0.309B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
CapsoVision (CV) United States $0.211B 0.00
Zepp Health (ZEPP) Netherlands $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.155B 0.00
Pulmonx (LUNG) United States $0.127B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.114B 0.00
CareCloud (CCLD) United States $0.101B 3.85
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.079B 0.00
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00